GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now emerging as a major focus in medical investigation, largely due to its notable impact on managing ailments such as second type diabetes and excess body fat. Recent trials have shown that in addition to glucose control, GLP-1 drugs offer potential for circulatory health and perhaps b